Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America ...Middle East

STOCKHOLM, Oct. 6, 2023 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) has completed the recruitment of 384 patients with onychomycosis (nail fungus) for the ongoing MOB-015 phase 3 study in North America. The aim is to provide a pivotal part of the clinical data set for registration and...

Hence then, the article about moberg pharma has completed enrollment to the phase 3 study for mob 015 in north america was published today ( Friday 06/10/2023 - 09:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America )

Also on site :

• Second PIC/S GMP Certification .. Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections
• Jim Morrison Said His Parents Were Dead. 62 Years Ago This Week, His Father May Have Started the Vietnam War. Morrison Defined Its Destruction.
• 1969 Hit, Reimagined by Reba McEntire Decades Later, Ranked Among ‘Greatest Country Songs of All Time’